Unexplained weight loss (UWL) is a common yet perplexing clinical presentation, often posing significant diagnostic challenges for clinicians. While it may be an indicator of underlying malignancy, infection, or other systemic diseases, in many instances, no clear etiology is found despite comprehensive evaluation.
The first step involves a comprehensive history and physical examination. Attention should be given to dietary intake, gastrointestinal symptoms, and psychosocial factors. Additionally, a review of medications can reveal possible iatrogenic causes. The physical examination should focus on signs of malnutrition, cachexia, and evidence of systemic disease.
Initial laboratory studies should include a complete blood count, comprehensive metabolic panel, thyroid function tests, and inflammatory markers. If these are inconclusive, further testing such as imaging studies or endoscopies may be warranted. However, the yield of these tests is often low without specific indications.
In elderly patients, UWL may be a sign of frailty or sarcopenia. In such cases, a comprehensive geriatric assessment can be beneficial. For patients with psychiatric symptoms, a thorough mental health evaluation is necessary as depression and anxiety are common causes of UWL.
Management is primarily directed at the underlying cause, if identified. In cases where no cause is found, emphasis should be placed on nutritional support and regular follow-up to monitor for the development of new symptoms or signs. It's crucial to maintain a high index of suspicion for serious underlying disease, especially in patients with significant weight loss.
Evaluating UWL requires a methodical and patient-centered approach. While it can be a diagnostic quandary, a comprehensive approach can help identify the cause in most patients, guiding appropriate treatment and follow-up. Continued research is needed to improve our understanding and management of this complex clinical scenario.
1.
Extracellular matrix pathway emerges as treatment target for pediatric cancer
2.
The New Canadian Guidelines for Drinking at High Risk, AUD.
3.
After a plane crash, a surgeon dies; Austin is released from the hospital; and an animal pandemic spreads.
4.
A paper strip test might enable the early detection of cancer.
5.
In leukemia, allogeneic HCT is beneficial following primary induction failure.
1.
Rehabilitation After Organ-Conserving Cancer Surgery
2.
Voices That Heal: Redefining Cancer Care Through Patient Insights and Partnership
3.
Intelligent Hematopoietic Cell-State Mapping: Transforming Diagnostic Precision and Clinical Decision-Making
4.
Multidisciplinary Lessons from a Cancer of Unknown Primary
5.
A Novel Gemcitabine-Releasing Intravesical System for Intermediate-Risk Non-Muscle-Invasive Bladder Cancer
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations
2.
Oropharyngeal Cancer in Relation to HPV Status
3.
Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma
4.
Understanding the causes of anemia in adults beyond nutritional deficiencies
5.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation